224 related articles for article (PubMed ID: 20812194)
1. The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis.
Hashemi M; Moazeni-Roodi AK; Fazaeli A; Sandoughi M; Taheri M; Bardestani GR; Zakeri Z; Kordi-Tamandani DM; Ghavami S
Genet Mol Res; 2010 Aug; 9(3):1735-41. PubMed ID: 20812194
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran.
Hashemi M; Moazeni-Roodi AK; Fazaeli A; Sandoughi M; Bardestani GR; Kordi-Tamandani DM; Ghavami S
Genet Mol Res; 2010 Feb; 9(1):333-9. PubMed ID: 20198589
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
4. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H
Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654
[TBL] [Abstract][Full Text] [Related]
5. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
[TBL] [Abstract][Full Text] [Related]
8. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
[TBL] [Abstract][Full Text] [Related]
10. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
[TBL] [Abstract][Full Text] [Related]
11. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.
Mattey DL; Nixon N; Dawes PT; Kerr J
Ann Rheum Dis; 2005 Aug; 64(8):1190-4. PubMed ID: 15695537
[TBL] [Abstract][Full Text] [Related]
14. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
15. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis.
Han SW; Kim GW; Seo JS; Kim SJ; Sa KH; Park JY; Lee J; Kim SY; Goronzy JJ; Weyand CM; Kang YM
Rheumatology (Oxford); 2004 Sep; 43(9):1173-7. PubMed ID: 15213335
[TBL] [Abstract][Full Text] [Related]
16. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
Deakin S; Leviev I; Brulhart-Meynet MC; James RW
Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
[TBL] [Abstract][Full Text] [Related]
18. Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.
Kim NS; Kang BK; Cha MH; Oh SM; Ko MM; Bang OS
Clin Biochem; 2009 Jun; 42(9):857-63. PubMed ID: 19233151
[TBL] [Abstract][Full Text] [Related]
19. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
20. Genetic association between single nucleotide polymorphisms in the paraoxonase 1 (PON1) gene and small-for-gestational-age birth in related and unrelated subjects.
Infante-Rivard C
Am J Epidemiol; 2010 May; 171(9):999-1006. PubMed ID: 20375196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
